Long-term	long-term	O	O
effects	effects	O	O
of	of	O	O
vincristine	vincristine	S_chemicals	O
on	on	O	O
the	the	O	O
peripheral	peripheral	O	O
nervous	nervous	O	B_disease
system	system	O	I_disease
.	.	O	O

Forty	forty	O	O
patients	patients	O	O
with	with	O	O
Non-Hodgkin	non-hodgkin	O	B_disease
's	's	O	I_disease
Lymphoma	lymphoma	O	S_disease
treated	treated	O	O
with	with	O	O
vincristine	vincristine	S_chemicals	O
between	between	O	O
1984	1984	O	O
and	and	O	O
1990	1990	O	O
(	(	O	O
cumulative	cumulative	O	O
dose	dose	O	O
12	12	O	O
mg	mg	O	O
in	in	O	O
18	18	O	O
-	-	O	O
24	24	O	O
weeks	weeks	O	O
)	)	O	O
were	were	O	O
investigated	investigated	O	O
in	in	O	O
order	order	O	O
to	to	O	O
evaluate	evaluate	O	O
the	the	O	O
long	long	O	B_disease
term	term	O	I_disease
effects	effects	O	O
of	of	O	O
vincristine	vincristine	S_chemicals	O
on	on	O	O
the	the	O	O
peripheral	peripheral	O	O
nervous	nervous	O	B_disease
system	system	O	I_disease
.	.	O	O

The	the	O	O
patients	patients	O	O
were	were	O	O
interviewed	interviewed	O	O
with	with	O	O
emphasis	emphasis	O	O
on	on	O	O
neuropathic	neuropathic	O	S_disease
symptoms	symptoms	O	O
.	.	O	O

Physical	physical	O	O
and	and	O	O
quantitative	quantitative	O	O
sensory	sensory	O	O
examination	examination	O	O
with	with	O	O
determination	determination	O	O
of	of	O	O
vibratory	vibratory	O	O
perception	perception	O	O
and	and	O	O
thermal	thermal	O	O
discrimination	discrimination	O	O
thresholds	thresholds	O	O
were	were	O	O
performed	performed	O	O
,	,	O	O
four	four	O	O
to	to	O	O
77	77	O	O
months	months	O	O
(	(	O	O
median	median	O	O
34	34	O	O
months	months	O	O
)	)	O	O
after	after	O	O
vincristine	vincristine	S_chemicals	O
treatment	treatment	O	O
.	.	O	O

Twenty-seven	twenty-seven	O	O
patients	patients	O	O
reported	reported	O	O
neuropathic	neuropathic	O	S_disease
symptoms	symptoms	O	O
.	.	O	O

In	in	O	O
13	13	O	O
of	of	O	O
these	these	O	O
27	27	O	O
patients	patients	O	O
symptoms	symptoms	O	O
were	were	O	O
still	still	O	O
present	present	O	O
at	at	O	O
the	the	O	O
time	time	O	O
of	of	O	O
examination	examination	O	O
.	.	O	O

In	in	O	O
these	these	O	O
patients	patients	O	O
sensory	sensory	O	O
signs	signs	O	B_disease
and	and	O	I_disease
symptoms	symptoms	O	I_disease
predominated	predominated	O	O
.	.	O	O

In	in	O	O
the	the	O	O
other	other	O	O
14	14	O	O
patients	patients	O	O
symptoms	symptoms	O	O
had	had	O	O
been	been	O	O
present	present	O	O
in	in	O	O
the	the	O	O
past	past	O	O
.	.	O	O

Symptoms	symptoms	O	O
persisted	persisted	O	O
maximally	maximally	O	O
40	40	O	O
months	months	O	O
since	since	O	O
cessation	cessation	O	O
of	of	O	O
therapy	therapy	O	O
.	.	O	O

There	there	O	O
was	was	O	O
no	no	O	O
age	age	O	O
difference	difference	O	O
between	between	O	O
patients	patients	O	O
with	with	O	O
and	and	O	O
without	without	O	O
complaints	complaints	O	O
at	at	O	O
the	the	O	O
time	time	O	O
of	of	O	O
examination	examination	O	O
.	.	O	O

Normal	normal	O	O
reflexes	reflexes	O	O
were	were	O	O
found	found	O	O
in	in	O	O
two	two	O	O
third	third	O	O
of	of	O	O
patients	patients	O	O
.	.	O	O

Neuropathic	neuropathic	O	S_disease
complaints	complaints	O	O
were	were	O	O
not	not	O	O
very	very	O	O
troublesome	troublesome	O	O
on	on	O	O
the	the	O	O
long	long	O	B_disease
term	term	O	I_disease
.	.	O	O

It	it	O	O
is	is	O	O
concluded	concluded	O	O
that	that	O	O
with	with	O	O
the	the	O	O
above	above	O	O
mentioned	mentioned	O	O
vincristine	vincristine	S_chemicals	O
dose	dose	O	O
schedule	schedule	O	O
signs	signs	O	B_disease
and	and	O	I_disease
symptoms	symptoms	O	I_disease
of	of	O	O
vincristine	vincristine	S_chemicals	O
neuropathy	neuropathy	O	O
are	are	O	O
reversible	reversible	O	O
for	for	O	O
a	a	O	O
great	great	O	O
deal	deal	O	O
and	and	O	O
prognosis	prognosis	O	S_disease
is	is	O	O
fairly	fairly	O	O
good	good	O	O
.	.	O	O

